Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 20, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - November 20, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/21/17 - "Benzazepine Sulfonamide Compounds" in Patent Application Approval Process (USPTO 20170275253)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors Hoves, Sabine; Koerner, Matthias; Wang, Lisha; Yun, Hongying; Zhu, Wei; Zhang, Weixing, filed on June 14, 2017, was made available online on October 5, 2017, according to news reporting originating from Washington, D.C., by NewsRx corresp
10/21/17 - "Pharmaceutical Composition Containing Ginkgolide B and Blood Platelet Prostaglandin Cyclooxygenase Inhibitor and Method for Preparation Thereof and...
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventor SUN, Yi, filed on September 25, 2015, was made available online on October 5, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Chengdu Baiyu Pharmaceutica
10/21/17 - $3 Million Available in Cooperative Agreement for Clinical Studies to Repurpose Therapeutics
The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award a cooperative agreement for supporting clinical studies to repurpose existing drugs or therapeutics. The award ceiling for this funding opportunity is $3 million. It was posted on Oct. 20 with an application closing date of Nov. 5, 202
10/21/17 - 287 Illegal Medicine Stores Sealed
No fewer than 287 illegal medicine stores operating in Kogi State have been sealed by the Pharmacists Council of Nigeria. The pharmaceutical and patent medicine stores were sealed up for various professional infractions. This was disclosed on Friday during a press conference in Lokoja by Deputy Director of Enforcement, Pharmacist Stephen Esumobi wh
10/21/17 - Activists Slam Ryan Costello's Entanglement in DEA/Pharma Scandal
Today, activists and community leaders held a press conference outside Representative Ryan Costello's office to hold him accountable for cosponsoring a bill that crippled the DEA's ability to stem the flow of prescription narcoticsselling his constituents out for $300,000 in Pharma money at the same fatal overdoses in Pennsylvania were...
10/21/17 - Astrocyte Pharmaceuticals, University of Texas System Assigned Patent for Compounds for Treating Neurological Conditions
Astrocyte Pharmaceuticals, Cambridge, Massachusetts, and the University of Texas System, Austin, Texas, have been assigned a patent developed by three co-inventors for "compounds and methods for treating neurological and cardiovascular conditions." The co-inventors are William S. Korinek, Mystic, Connecticut, James D. Lechleiter, San Antonio, and T
10/21/17 - Azerbaijan producing domestic medicine
Azerbaijan, fully dependent on imported medicine, will start its own production of drugs. With the financial support of the Science Development Fund, a modern pharmacy research laboratory has been established in the country. Head of the Laboratory Tahir Suleymanov said that Azerbaijan has up to 5,000 types of medicinal plants.
10/21/17 - Big Pharma's opioid gambit
For decades, America has waged an ineffective war on drug pushers and drug lords, from Bronx street corners to Medellin, Colombia, regarding them as among the most contemptible specimens of humanity. Big Pharma should be writhing in embarrassment this week after The Washington Post and 60 Minutes reported that pharmaceutical lobbyists had man
10/21/17 - Brain damage caused by Zika exposure in utero can be detected by both fetal MRI and ultrasound
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week SAN DIEGO Clinicians managing Zika-affected pregnancies should use magnetic resonance imaging in addition to standard ultrasound because the more detailed MRI images can reveal more extensive areas of damage to the developing fetal brain, according to research presented dur
10/21/17 - Carlos Trejo Sosa: We Have Native Doctors in Cuba Like Nigeria
Carlos Trejo Sosa, the Cuban Ambassador to Nigeria tells Stanley Nkwazema about the country s 2018 elections, the first in several years Historic Moments of 1974 Carlos Trejo Sosa, the Cuban Ambassador to Nigeria, was full of praises for THISDAY. He just could not hide it. Your newspaper has paid a lot of attention to Cuba; we are pleased tha
10/21/17 - CorrexHassan-mf-vn-102117
Maggie Hassan, D- N.H., has received $64,383 from the pharmaceutical industry since 2013. An article in Friday s Valley News about a law passed last year that has hampered the Drug Enforcement Agency s ability to stop the diversion of prescription drugs to the black market inaccurately reported the period when those contributions were made.
10/21/17 - Dicerna Pharmaceuticals Assigned Patent for Phase Changing Formulations of Nucleic Acid Payloads
Dicerna Pharmaceuticals, Cambridge, Massachusetts, has been assigned a patent developed by two co-inventors for "phase changing formulations of nucleic acid payloads." The co-inventors are Bob Dale Brown, Millington, New Jersey, and Sujit Kumar Basu, Newton, Massachusetts. Written by Deviprasad Jena; edited by Sudarshan Harpal.
10/21/17 - Ebola vaccine wins approval from regulators [China Daily: Africa Weekly]
This makes China the third country, after the United States and Russia, with vaccines available for use to combat the deadly infectious disease, the China Food and Drug Administration said. The vaccine improves China's ability to prevent and control major public health threats and provides a new means for China to handle global disease epidemics ef
10/21/17 - FDA approves better vaccine against painful shingles virus
Drugmaker GlaxoSmithKline said the Food and Drug Administration approved it late Friday. Studies paid for by Glaxo found it prevents shingles in about 90 per cent of people. Merck' s is about 50 per cent effective. The U.S. Centers for Disease Control and Prevention, though, recommends vaccination for those 60 or older, partly because it loses effe
10/21/17 - IBM Watson Health Head of West Coast Sales Joins Deep 6 AI
PASADENA, CA- 21 Oct, 2017- Former IBM Watson Health sales executive, Bill Hutchins, is joining Deep 6 AI to support the rapid expansion of its clinical trial patient recruitment platform across hospitals, pharmaceutical companies and contract research organizations. Hutchins previously served as IBM Watson for Oncology Sales Director- Western US w
10/21/17 - Lantheus Medical Imaging Assigned Patent for Methods for Making Ultrasound Contrast Agents
Lantheus Medical Imaging, North Billerica, Massachusetts, has been assigned a patent developed by six co-inventors for "methods for making ultrasound contrast agents." The co-inventors are Simon P. Robinson, Stow, Massachusetts, Robert W. Siegler, Chelmsford, Massachusetts, Nhung Tuyet Nguyen, Westford, Massachusetts, David C. Onthank, Groton, Mass
10/21/17 - MOHAP signs agreement with Neopharma Factory to increase emergency medicines inventory [Emirates News Agency (WAM) (United Arab Emirates)]
ABU DHABI, 21st October, 2017 The Ministry of Health and Prevention, MOHAP, has recently signed an agreement with the Neopharma Factory to provide medical stocks used for emergency situations, including 103 types of pharmaceutical products, to further enhance the country's health security following the issuance of Ministerial Resolution No. 39 of
10/21/17 - New GlaxoSmithKline shingles vaccine gets FDA approval [Philly.com]
Oct. 21 GlaxoSmithKline's new shingles vaccine, Shingrix, was approved Friday by the Food and Drug Administration, a potential $1 billion- a-year drug to prevent the shingles virus in adults 50 and older. The final step will be for the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices to sign off for the us
10/21/17 - PTC THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of PTC Therapeutics, Inc. - (PTCT)
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick& Foti, LLC, announces that KSF has commenced an investigation into PTC Therapeutics, Inc.. On February 23, 2016, PTC revealed that it had received a Refuse to File letter from the U.S. FDA on its New Drug Application for its primary drug Transl
10/21/17 - Rep. Krishnamoorthi Joins Colleagues in Demanding Answers on the DEA's Relationship With the Pharmaceutical Industry
Raja Krishnamoorthi, D- Ill., issued the following news release:. Today, Congressman Raja Krishnamoorthi joined Congressmen Mark DeSaulnier, Jim Cooper, Jamie Raskin, and Matt Cartwright in sending a letter to the Acting Director of the Drug Enforcement Administration demanding answers about the agency's failure to disclose its concerns about effor
10/21/17 - Senate Aging Committee Issues Testimony From National Institute of Diabetes
The Senate Special Committee on Aging issued the following testimony by Griffin Rodgers, director of the National Institute of Diabetes and Digestive and Kidney Diseases, at a hearing entitled "Progress Toward a Cure for Type I Diabetes: Research and the Artificial Pancreas":. On behalf of NIDDK and the other Institutes and Centers of the National
10/21/17 - Shingrix Approved in the US for Prevention of Shingles in Adults Aged 50 and Over
GlaxoSmithKline issued the following news release:. GlaxoSmithKline plc today announced that the US Food and Drug Administration has approved Shingrix for the prevention of shingles in adults aged 50 years and older. Thomas Breuer, Senior Vice President and Chief Medical Officer of GSK Vaccines said: "Shingrix represents a significant scientific...
10/21/17 - Solixa Technologies Assigned Patent for Aqueous Drug Delivery System
Solixa Technologies, Scituate, Massachusetts, has been assigned a patent developed by Kyle A. Reed, Manalapan, New Jersey, for an "aqueous drug delivery system." The patent application was filed on March 30, 2015. Written by Kusum Sangma; edited by Sudarshan Harpal.
10/21/17 - Tanner Pharma Group to Attend Upcoming CPHI Worldwide Conference
Top executives from Tanner Pharma Group, a Charlotte- based global pharmaceutical services company, will attend the CPhI Worldwide event on October 24- 26 in Messe Frankfurt, Germany. Tanner Pharma leverages more than 15 years of pharma services experience to provide regulatory compliance and logistical efficiency, all within an EU-GDP compliant
10/21/17 - Vertex Pharmaceuticals Assigned Patent for Method for Measuring ATR Inhibition Mediated Increases in DNA Damage
Vertex Pharmaceuticals, Boston, and the University of Newcastle Upon Tyne, Newcastle Upon Tyne, United Kingdom, have been assigned a patent developed by six co-inventors for a "method for measuring ATR inhibition mediated increases in DNA damage." The co-inventors are Susanna Falcon, Newbury, United Kingdom, Philip Reaper, Shillingford, United King
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415